<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Hao Li | Xu Lab</title><link>https://xushidang-lab.netlify.app/author/hao-li/</link><atom:link href="https://xushidang-lab.netlify.app/author/hao-li/index.xml" rel="self" type="application/rss+xml"/><description>Hao Li</description><generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en-us</language><lastBuildDate>Fri, 29 Aug 2025 00:00:00 +0000</lastBuildDate><image><url>https://xushidang-lab.netlify.app/media/icon_hu16174698449664387463.png</url><title>Hao Li</title><link>https://xushidang-lab.netlify.app/author/hao-li/</link></image><item><title>Anti-Triggering Receptor Expressed on Myeloid Cells 2-Conjugated Nanovesicles Loaded Vadimezan Reprogram Tumor-Associated Macrophages to Combat Recurrent Lung Cancer</title><link>https://xushidang-lab.netlify.app/publication/2025-trem2-nanovesicles/</link><pubDate>Fri, 29 Aug 2025 00:00:00 +0000</pubDate><guid>https://xushidang-lab.netlify.app/publication/2025-trem2-nanovesicles/</guid><description>&lt;p>Read the &lt;a href="https://pubs.acs.org/doi/10.1021/acsnano.5c10375" target="_blank" rel="noopener">publisher record&lt;/a> for the abstract and access options.&lt;/p></description></item></channel></rss>